Back to all press releases

Continuity Software Received $1M Investment From the Israeli Government’s Chief Scientist

Funds will be used to accelerate development of RecoverGuard™, a suite of Business Continuity Management Software solutions

Hertzlia, ISRAEL, January 3, 2006 – Continuity Software Inc., a leading provider of Business Continuity software solutions, announced today that it has received an investment of approximately $1M from the Office of the Chief Scientist of the Israeli Ministry of Industry and Trade (OCS). The funding supplements the recently announced round of venture funding led by Giza Venture Capital.

“We are proud with the vote of confidence by the Office of the Chief Scientist and are delighted to continue and contribute to the growth of the technology industry in Israel”, said Gil Hecht, Founder and Chief Executive Officer of Continuity Software. “Our team is committed to solving the Business Continuity complexity crisis by bringing the leading Data Protection Management solutions to market.”

Continuity Software is well positioned to capitalize on the growing demand for Business Continuity and Data Protection Management solutions that helps companies enhance their recovery readiness while significantly reducing costs. The patent pending RecoverGuard™ solution helps customers ensure that all critical data is properly protected, and enforces the Business Continuity SLA.

 About Continuity Software, Inc

Founded in 2005, Continuity Software, Inc is the leading provider of Business Continuity management software. Our flagship product, RecoverGuard™, is the first Business Continuity monitoring solution which empowers customers to effectively manage Business Continuity implementations, ensure their critical business data is protected, and maintain Business Continuity SLA. For more information, please visit www.ContinuitySoftware.com

 Media Contacts:

Continuity Software, inc: PR@ContinuitySoftware.com

+1 646 216 8628

We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you.
We may also place cookies on our and our partners’ behalf to help us deliver more targeted ads and assess the performance of these campaigns. You may review our
Privacy Policy I Agree